Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Aetna Ready For 'Dual Eligibles' Despite Commercial Focus - CFO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/19/2012 | 09:55pm CET
   By Jon Kamp 
   Of  
 

Aetna Inc. (>> Aetna Inc.) believes it can ably serve health-challenged patients covered by both Medicare and Medicaid, even though the company doesn't have a major stake in those markets.

Additionally, the commercially-focused health insurer doesn't need acquisitions to win business for "dual eligible" patients, according to Chief Financial Officer Joseph Zubretsky. Some of Aetna's big competitors have recently made deals with an eye on dual patients, and Aetna has faced questions about whether it has the right make-up for the market.

"I do believe we'll have the platforms built to be able to respond to this opportunity," Zubretsky said, speaking during an interview at Aetna's Hartford headquarters.

The market has significant potential, but will build over several years, giving Aetna time to grow its businesses from within, Zubretsky said. Meantime, Aetna has the capabilities within these businesses to address the kind of complex health problems dual patients often present, he said.

Dual patients, who represent a potential $300 billion market for health insurers, have become a hot topic as states and the federal government look for ways to better coordinate care and save money. These patients tend to rack up high costs due to their health challenges. A handful of states could have programs for covering dual patients up and running next year, and the market is expected to continue growing in subsequent years.

Managed-care companies could be big beneficiaries, but questions abound about which firms are best positioned to win state-by-state contracts. Analysts view Medicaid-focused insurers such as Molina Healthcare Inc. (>> Molina Healthcare, Inc.) and Centene Corp. (>> Centene Corp) as potential winners, and bigger insurers such as UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) and WellPoint Inc. (WLP) are also expected to compete based on their presence in both the Medicaid and Medicare markets.

Aetna has modest stakes in markets for government-based plans. At the end of last year, roughly 90% of Aetna's 18.5 million medical members were on commercial health plan, which are typically plans provided through employers.

Citigroup analyst Carl McDonald recently said Aetna's valuation has been hurt by "the company's lack of government exposure". Still, Aetna shares are up 33% over the last year, helped by patients keeping a lid on health costs after the recession.

Competitors including UnitedHealth, WellPoint and Cigna Inc. (CI) have all recently made Medicare-focused acquisitions that could improve their chances in the duals market. Aetna has been wary of paying too much, however, and feels there is time to build up its own businesses.

"The opportunity has been reflected in certain managed care valuations long before the revenue is ever going to show up," Zubretsky said. "This is not a cataclysmic event where $300 billion dollars is going to race into the market inside of 12 months. It's going to happen in a phased approach."

Aetna Chief Executive Mark Bertolini has talked about the company's ability to grow its Medicare business by keeping commercial members on Aetna plans when they switch over to Medicare. There are about 1.2 million Medicare-eligible members in the company's commercial membership. He also noted Aetna has more than doubled revenue in its Medicaid business since acquiring it in 2007.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
02/26 DEADLINE ALERT : Brower Piven Alerts Shareholders Of Approaching Deadline In Cla..
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/22 Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. an..
02/22 AETNA INC : Lundin Law PC Announces Securities Class Action Lawsuit against Aetn..
02/22 AETNA INC /PA/ : Entry into a Material Definitive Agreement, Creation of a Direc..
02/22 AET The Law Offices of Vincent Wong Reminds Investors of Commencement of a Cl..
02/22 AETNA : Health insurer Aetna to spend $3.3B buying back stock
02/22 AETNA : Announces $3.3 Billion Accelerated Share Repurchase
02/21 AETNA : Introducing Aetna Better Health of Florida®
02/21 AETNA INC : SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action ..
More news
Sector news : Managed Healthcare - NEC
02/24DJTrump to Meet With Insurance Executives on Repeal of Affordable Care Act -- U..
02/23 CIGNA : CFO Thomas McCarthy to retire
02/17DJAETNA : Doubles Dividend, Boosts Stock Buyback Plans
02/16DJCIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With ..
02/16DJANTHEM : Countersues After Cigna Ends Deal -- WSJ
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
02/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2016 Updat..
02/22 Aetna initiates accelerated $3.3B share buyback
02/17 Aetna declares $0.50 dividend
02/17 Aetna authorizes $4B repurchase, declares $0.50 per share quarterly dividend
02/15 Trump administration proposes changes to ACA to reduce sign-ups by sick peopl..
Advertisement
Financials ($)
Sales 2017 60 289 M
EBIT 2017 4 672 M
Net income 2017 2 344 M
Debt 2017 2 991 M
Yield 2017 1,18%
P/E ratio 2017 19,09
P/E ratio 2018 14,14
Capi. / Sales 2017 0,80x
Capi. / Sales 2018 0,71x
Capitalization 45 256 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 140 $
Spread / Average Target 8,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC4.61%45 256
UNITEDHEALTH GROUP INC1.60%155 097
ANTHEM INC14.02%43 159
CIGNA CORPORATION10.59%37 751
HUMANA INC0.48%30 952
CENTENE CORP24.90%12 147
More Results